Requirement_NN
of_IN
GATA-1_NN
and_CC
p45_NN
NF-E2_NN
expression_NN
in_IN
butyric_JJ
acid-induced_JJ
erythroid_JJ
differentiation_NN
._.

Butyric_JJ
acid_NN
-LRB-_-LRB-
BA_NN
-RRB-_-RRB-
is_VBZ
known_VBN
to_TO
induce_VB
overexpression_NN
of_IN
fetal_JJ
hemoglobin_NN
and_CC
then_RB
erythroid_JJ
differentiation_NN
._.

Therefore_RB
,_,
BA_NN
is_VBZ
currently_RB
under_IN
clinical_JJ
investigation_NN
as_IN
a_DT
potential_JJ
therapy_NN
for_IN
the_DT
treatment_NN
of_IN
sickle_JJ
cell_NN
disease_NN
and_CC
cancer_NN
._.

Nevertheless_RB
,_,
the_DT
molecular_JJ
mechanisms_NNS
involved_VBN
in_IN
BA-induced_JJ
differentiation_NN
remain_VBP
largely_RB
unknown_JJ
._.

Previous_JJ
reports_NNS
have_VBP
shown_VBN
that_IN
BA-induced_JJ
overexpression_NN
of_IN
erythroid_JJ
genes_NNS
occurred_VBD
at_IN
the_DT
transcriptional_JJ
level_NN
,_,
suggesting_VBG
the_DT
involvement_NN
of_IN
erythroid_JJ
transcription_NN
factors_NNS
._.

Here_RB
,_,
we_PRP
intend_VBP
to_TO
demonstrate_VB
the_DT
requirement_NN
of_IN
GATA-1_NN
and_CC
NF-E2_NN
transcription_NN
factors_NNS
in_IN
the_DT
BA-induced_JJ
erythroid_JJ
differentiation_NN
of_IN
human_JJ
leukemic_JJ
K562_NN
cells_NNS
._.

Time-course_JJ
experiments_NNS
showed_VBD
that_IN
nuclear_JJ
levels_NNS
of_IN
GATA-1_NN
and_CC
p45_NN
NF-E2_NN
proteins_NNS
increased_VBD
during_IN
BA_NN
treatment_NN
._.

Moreover_RB
,_,
antisense_JJ
oligodeoxynucleotides_NNS
targeting_VBG
either_CC
GATA-1_NN
or_CC
p45_NN
NF-E2_NN
proteins_NNS
inhibited_VBD
both_CC
protein_NN
expression_NN
and_CC
BA-induced_JJ
differentiation_NN
._.

In_IN
contrast_NN
,_,
BA-induced_JJ
cell_NN
growth_NN
inhibition_NN
was_VBD
not_RB
affected_VBN
._.

These_DT
results_NNS
provide_VBP
the_DT
first_JJ
direct_JJ
evidence_NN
for_IN
the_DT
requirement_NN
of_IN
GATA-1_NN
and_CC
NF-E2_NN
in_IN
BA-induced_JJ
differentiation_NN
process_NN
._.

